Bevacizumab bei neu diagnostiziertem Glioblastom: Ja?
Crossref DOI link: https://doi.org/10.1007/s15005-014-0807-5
Published Online: 2014-04-15
Published Print: 2014-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weller, Michael
Text and Data Mining valid from 2014-04-01